Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.
Clinical trial NCT05068427 · COMPLETED
Trial details
- NCT number
- NCT05068427
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-23
- Primary completion
- 2023-02-23
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.